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Dear Editor,
We thank Drs. Tfelt-Hansen and Ashina [1] for their
interest in our article [2]. They have raised a valid point,
namely that measurement units should be similar in the
scientific literature. We assume that different units men-
tioned in previous studies were provided by the respective
manufacturer of the kit, and we followed the same custom.
However, in the interest of uniformity in the literature, as
indicated by Drs. Tfelt-Hansen and Ashina, we provide
revised results here (Table 1).
A concern was raised regarding the higher inter-ictal
concentration of plasma CGRP in the cubital blood than
reported in previous studies [3–7]. The available litera-
ture provides conflicting results regarding plasma
CGRP concentration in migraineurs, both ictal as well
as inter-ictal, and even when the blood was collected
from different areas (external jugular/internal jugular
and cubital) [2–9]. Hence, no conclusion can be reached
regarding the baseline concentration of CGRP in
plasma. The higher concentration reported in the present
study than in previous studies can be explained by a
number of methodological factors. First, the CGRP has a
very short half life, barely 7 min, hence we made sure
that plasma samples were frozen to -70C within 5 min
of drawing the blood [10, 11]. In a number of studies the
sample was centrifuged for 15 min [6, 8, 12]. This could
have resulted in lower levels. Secondly, it must be
remembered that peptides are unstable molecules and
they need to be preserved at -70C. At least in one
study samples were stored at –20C until analysis, and
this could have affected the results [13]. Moreover, the
plasma level of CGRP follows a circadian pattern and
shows troughs and peaks, but at different times
according to different studies [14, 15]. We had drawn
blood samples between 9 a.m. and 12 noon, when CGRP
concentration is highest [14]. Furthermore, sampling
methods and anticoagulants may affect the quantitative
analysis with some peptides [16]. These factors could
have affected the results of previous studies as they used
different anticoagulants, e.g. heparin or aprotinin [6, 8,
13]. We used EDTA tubes to collect the blood on the
manufacturer’s recommendation. Lastly, the measure-
ment of CGRP is influenced by a number of factors
present in the plasma that may cross-react with it
(Peninsula Lab Inc., LLC), hence we used the extrac-
tion-free kit. This further reduces the chances of error.
The sensitivity of the ELISA kit used in this study was
21 pmol/l and the range was 0–6596 pmol/l (Peninsula Lab
Inc., LLC) with intra-assay variation of less than 5%.
Thus, the results of these kinds of studies warrant further
studies in this area with better methodologies, until con-
clusive evidence is yielded.
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Table 1 Plasma CGRP levels (pmol/l) among diagnostic sub-groups of migraineurs
Diagnosis n Mean Standard deviation 95% confidence interval for mean Minimum Maximum
Lower limit Upper limit
MO 37 303.43 154.11 255.93 350.92 182.05 817.94
MOMA 7 271.76 36.93 237.46 306.06 208.44 308.70
MA 6 303.43 131.92 163.58 443.27 179.42 554.09
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